logo

For the Inventor, By the Inventor

Louviers, France

Isabelle Noëlle Constance Pilatte

This inventor holds 40 USPTO granted patents and 3 published patent applications and 15 EPO patents, primarily in Histone Deacetylase Inhibitors. Top assignees: Janssen Pharmaceutica Nv, Astex Therapeutics Limited, Other. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isabelle Noëlle Constance Pilatte. Retrieved from https://idiyas.com/inventor/isabelle-noelle-constance-pilatte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 

% Patents Active = 85.0

 

Average Co-Inventor Count = 6.2

ph-index = 15

Forward Citations = 473(Granted Patents)


Location History:

  • Val de Reuil, FR (2016)
  • Issy-les-Moulineaux, FR (2021)
  • Louviers, FR (2006 - 2024)

Company Filing History:

goldMedal32 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal7 out of 126 
 
Astex Therapeutics Limited
 patents
bronzeMedal1 out of 834,570 
Other
 patents

Years Active: 2006-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Histone Deacetylase
Pyrazolyl Quinoxaline
Indolyl Derivatives
Farnesyl Transferase
Menin-MLL Interaction
PI3K Inhibitors
Quinazolinone Derivatives
Sulfonyl Derivatives
Bicyclic Inhibitors
Azepane Inhibitors
Kinase Inhibitors
Aminopropenyl Derivatives
40 patents (USPTO):Explore Patents
1. 12084462 - Spiro bicyclic inhibitors of menin-MLL interaction (2024-09-10),
2. 11530226 - Azepane inhibitors of menin-MLL interaction (2022-12-20),
3. 11220517 - Spiro bicyclic inhibitors of menin-MLL interaction (2022-01-11),
4. 10894793 - Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors (2021-01-19),
5. 10745409 - Azepane inhibitors of menin-MLL interaction (2020-08-18),
6. 10519137 - Pyrazolyl quinoxaline kinase inhibitors (2019-12-31),
7. 10202387 - Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors (2019-02-12),
8. 10087187 - Imidazopyridazine derivatives as PI3KB inhibitors (2018-10-02),
9. 9850228 - Pyrazolyl quinoxaline kinase inhibitors (2017-12-26),
10. 9737544 - Compounds (2017-08-22),
11. 9636341 - Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase (2017-05-02),
12. 9493426 - Quinazolinone derivatives useful as FGFR kinase modulators (2016-11-15),
13. 9464071 - Pyrazolyl quinoxaline kinase inhibitors (2016-10-11),
14. 9303030 - Compounds (2016-04-05),
15. 9150543 - Substituted indolyl alkyl amino derivatives as inhibitors of histone deacetylase (2015-10-06),

Title: Inventor Isabelle Noëlle Constance Pilatte

Introduction: Isabelle Noëlle Constance Pilatte, a notable inventor from Louviers, France, is recognized for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Isabelle Noëlle Constance Pilatte's most recent patents focus on advancements in renewable energy technologies, particularly in the development of solar-powered devices for sustainable living.

Career Highlights: Throughout his illustrious career, Isabelle Noëlle Constance Pilatte has been instrumental in creating innovative solutions for environmental challenges, earning him accolades and recognition in the scientific community.

Collaborations: Isabelle Noëlle Constance Pilatte has collaborated with leading research institutions and universities worldwide to further his research and bring his inventions to life, showcasing his dedication to pushing the boundaries of technological innovation.

Conclusion: Isabelle Noëlle Constance Pilatte's passion for innovation and commitment to creating a more sustainable future through his inventions solidify his legacy as a pioneering inventor in the realm of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…